Cytokinetics

+$0.32 (+1.09%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.

About CYTK

Cytokinetics, Inc. operates as a biopharmaceutical company. The firm focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases.

CEO
Robert I. Blum
Employees
184
Headquarters
South San Francisco, California
Founded
1997

CYTK Key Statistics

Market Cap
2.47B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
7.37M
High Today
$29.92
Low Today
$28.84
Open Price
$28.95
Volume
782.47K
52 Week High
$31.41
52 Week Low
$14.71

CYTK Earnings

-$0.68
-$0.45
-$0.23
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure